Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
Conditions
Brain and Central Nervous System Tumors | Kidney Cancer | Sarcoma
What is the purpose of this trial?
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.
PURPOSE: This randomized phase III trial is studying combination chemotherapy in treating patients with non-metastatic extracranial Ewing sarcoma.
Participation Guidelines
- Age:
- Up to 50 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Children's Oncology Group
National Cancer Institute (NCI) - Dates:
- November 2010
- Last Updated:
- August 5, 2012
- Study HIC#:
- 1101007854
Clinicaltrials.gov ID: NCT01231906
For more information about this trial, contact:
Investigator
Gary Kupfer, MD
Principal Investigator
